These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 21642354

  • 1. p54nrb is a new regulator of progression of malignant melanoma.
    Schiffner S, Zimara N, Schmid R, Bosserhoff AK.
    Carcinogenesis; 2011 Aug; 32(8):1176-82. PubMed ID: 21642354
    [Abstract] [Full Text] [Related]

  • 2. Melanoma inhibitory activity promotes melanoma development through activation of YBX1.
    Schmid R, Meyer K, Spang R, Schittek B, Bosserhoff AK.
    Pigment Cell Melanoma Res; 2013 Sep; 26(5):685-96. PubMed ID: 23672612
    [Abstract] [Full Text] [Related]

  • 3. The mitotic phosphorylation of p54(nrb) modulates its RNA binding activity.
    Bruelle C, Bédard M, Blier S, Gauthier M, Traish AM, Vincent M.
    Biochem Cell Biol; 2011 Aug; 89(4):423-33. PubMed ID: 21819346
    [Abstract] [Full Text] [Related]

  • 4. p54(nrb)/NONO regulates lipid metabolism and breast cancer growth through SREBP-1A.
    Zhu Z, Zhao X, Zhao L, Yang H, Liu L, Li J, Wu J, Yang F, Huang G, Liu J.
    Oncogene; 2016 Mar 17; 35(11):1399-410. PubMed ID: 26148231
    [Abstract] [Full Text] [Related]

  • 5. YBX1 is a modulator of MIA/CD-RAP-dependent chondrogenesis.
    Schmid R, Meyer K, Spang R, Schittek B, Bosserhoff AK.
    PLoS One; 2013 Mar 17; 8(12):e82166. PubMed ID: 24349210
    [Abstract] [Full Text] [Related]

  • 6. Decreased expression of P54(nrb) /NonO correlates with collagen deposition and fibrosis in human aortic dissection.
    Ren Z, Wang Z, Hu Z, Hu X, Zhang H, Wu H, Hu R, Liu H.
    Histopathology; 2014 Oct 17; 65(4):570-80. PubMed ID: 24720418
    [Abstract] [Full Text] [Related]

  • 7. p54nrb/NONO regulates cyclic AMP-dependent glucocorticoid production by modulating phosphodiesterase mRNA splicing and degradation.
    Lu JY, Sewer MB.
    Mol Cell Biol; 2015 Apr 17; 35(7):1223-37. PubMed ID: 25605330
    [Abstract] [Full Text] [Related]

  • 8. Functional role of MIA in melanocytes and early development of melanoma.
    Poser I, Tatzel J, Kuphal S, Bosserhoff AK.
    Oncogene; 2004 Aug 12; 23(36):6115-24. PubMed ID: 15208686
    [Abstract] [Full Text] [Related]

  • 9. Brm transactivates the telomerase reverse transcriptase (TERT) gene and modulates the splicing patterns of its transcripts in concert with p54(nrb).
    Ito T, Watanabe H, Yamamichi N, Kondo S, Tando T, Haraguchi T, Mizutani T, Sakurai K, Fujita S, Izumi T, Isobe T, Iba H.
    Biochem J; 2008 Apr 01; 411(1):201-9. PubMed ID: 18042045
    [Abstract] [Full Text] [Related]

  • 10. The multifunctional protein p54nrb/PSF recruits the exonuclease XRN2 to facilitate pre-mRNA 3' processing and transcription termination.
    Kaneko S, Rozenblatt-Rosen O, Meyerson M, Manley JL.
    Genes Dev; 2007 Jul 15; 21(14):1779-89. PubMed ID: 17639083
    [Abstract] [Full Text] [Related]

  • 11. Structure, Dynamics, and Interaction of p54(nrb)/NonO RRM1 with 5' Splice Site RNA Sequence.
    Duvignaud JB, Bédard M, Nagata T, Muto Y, Yokoyama S, Gagné SM, Vincent M.
    Biochemistry; 2016 May 10; 55(18):2553-66. PubMed ID: 27064654
    [Abstract] [Full Text] [Related]

  • 12. Melanoma-inhibiting activity (MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal origin.
    Hau P, Apfel R, Wiese P, Tschertner I, Blesch A, Bogdahn U.
    Anticancer Res; 2002 May 10; 22(2A):577-83. PubMed ID: 12014625
    [Abstract] [Full Text] [Related]

  • 13. Sepantronium bromide (YM155) induces disruption of the ILF3/p54(nrb) complex, which is required for survivin expression.
    Yamauchi T, Nakamura N, Hiramoto M, Yuri M, Yokota H, Naitou M, Takeuchi M, Yamanaka K, Kita A, Nakahara T, Kinoyama I, Matsuhisa A, Kaneko N, Koutoku H, Sasamata M, Kobori M, Katou M, Tawara S, Kawabata S, Furuichi K.
    Biochem Biophys Res Commun; 2012 Sep 07; 425(4):711-6. PubMed ID: 22842455
    [Abstract] [Full Text] [Related]

  • 14. Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma.
    Hau P, Ruemmele P, Kunz-Schughart LA, Doerfelt A, Hirschmann B, Lohmeier A, Koch H, Mueller A, Bogdahn U, Bosserhoff AK.
    Oncol Rep; 2004 Dec 07; 12(6):1355-64. PubMed ID: 15547763
    [Abstract] [Full Text] [Related]

  • 15. Involvement of p54(nrb), a PSF partner protein, in DNA double-strand break repair and radioresistance.
    Li S, Kuhne WW, Kulharya A, Hudson FZ, Ha K, Cao Z, Dynan WS.
    Nucleic Acids Res; 2009 Nov 07; 37(20):6746-53. PubMed ID: 19759212
    [Abstract] [Full Text] [Related]

  • 16. Proteomic identification of PSF and p54(nrb) as TopBP1-interacting proteins.
    Kuhnert A, Schmidt U, Monajembashi S, Franke C, Schlott B, Grosse F, Greulich KO, Saluz HP, Hänel F.
    J Cell Biochem; 2012 May 07; 113(5):1744-53. PubMed ID: 22213094
    [Abstract] [Full Text] [Related]

  • 17. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
    Mühlbauer M, Langenbach N, Stolz W, Hein R, Landthaler M, Buettner R, Bosserhoff AK.
    Clin Cancer Res; 1999 May 07; 5(5):1099-105. PubMed ID: 10353744
    [Abstract] [Full Text] [Related]

  • 18. P54/nrb prompts rheumatoid arthritis progression mainly by transcriptionally activating NF-κB signaling.
    Li Q, Guo H, Li H, Zhu Q, Liu Y.
    Pharmazie; 2017 May 01; 72(5):260-264. PubMed ID: 29441870
    [Abstract] [Full Text] [Related]

  • 19. Cadherin-7 interacts with melanoma inhibitory activity protein and negatively modulates melanoma cell migration.
    Winklmeier A, Contreras-Shannon V, Arndt S, Melle C, Bosserhoff AK.
    Cancer Sci; 2009 Feb 01; 100(2):261-8. PubMed ID: 19200257
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
    Vogt T, Stolz W, Welsh J, Jung B, Kerbel RS, Kobayashi H, Landthaler M, McClelland M.
    Clin Cancer Res; 1998 Mar 01; 4(3):791-7. PubMed ID: 9533549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.